Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

S&P Midcap 400 Divd Proshares (REGL)

$56.59 0.35 (0.61%)

18:30 EDT REGL Stock Quote Delayed 30 Minutes

Volume:

Previous Close $56.59

Market Cap 437.16M

PE Ratio -

EPS -

Volume (Avg. Vol.) 51,731

Day's Range 56.38 - 56.89

52-Week Range 37.74 - 61.37

Dividend & Yield 1.08 (1.91%)

REGL Stock Predictions, Articles, and S&P Midcap 400 Divd Proshares News

From InvestorPlace
From the Web

5 Dividend Aristocrat ETFs Perfect for Building an Income Portfolio

By Todd Shriber, InvestorPlace Contributor Apr 6, 2020

With S&P 500 dividends under duress this year, investors should focus on quality dividend aristocrat ETFs that offer impressive growth.

5 High-Fee ETFs Worth Buying Despite Hefty Expense Ratios

By Todd Shriber, InvestorPlace Contributor Oct 7, 2019

With all the cheap ETFs on the market, investors often think that the cheapest funds are the best ETFs to buy. But these ETFs earn their fees.

Are These 7 Dividend Aristocrats ETFs Fit for a King?

By Todd Shriber, InvestorPlace Contributor May 9, 2019

Several ETFs track indices known as 'dividend aristocrats' indices. These funds emphasize dividend growth, not yield, and they're not perfect ...

7 Mid-Cap Dividend ETFs to Buy

By Todd Shriber, InvestorPlace Contributor Dec 4, 2018

While the number of dedicated mid-cap dividend ETFs remains small, mid caps' have, in recent years, been displaying solid dividend growth.

5 Dividend Aristocrat ETFs for a Growing Retirement Income

By Will Healy, InvestorPlace Contributor Jul 6, 2018

Retirement stocks can often be limited with 401k investing, but when investing for retirement, dividend aristocrat funds can provide a healthy combination of income and growth.

3 Mid-Cap Dividend ETFs for Massive Income

By Todd Shriber, InvestorPlace Contributor Feb 21, 2018

Mid-cap dividend ETFs are often ignored, but they shouldn't be. Here's what investors need to know about the benefits of ETFs that emphasize mid-cap stocks and dividends.

Compare Brokers

Ovid Therapeutics (OVID) Received its Third Buy in a Row

From Smarter Analyst Aug 11, 2020

After William Blair and JMP Securities gave Ovid Therapeutics (NASDAQ: OVID) a Buy rating last month, the company received another Buy, this time from

Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

From BusinessInsider Aug 10, 2020

Announces completion of enrollment in the pivotal Phase 3 NEPTUNE trial with OV101 in Angelman syndrome; topline results expected in Q4 2020Multip...

Ovid Therapeutics EPS misses by $0.05 (NASDAQ:OVID)

From Seeking Alpha Aug 10, 2020

Ovid Therapeutics (NASDAQ:OVID): Q2 GAAP EPS of -$0.41 misses by $0.05.Cash and cash equivalents of $41.3M; additionally, received an upfront net payment from Angelini Pharma of $19.6M in July.Press Release

Ovid Therapeutics (OVID) Received its Third Buy in a Row

From Analyst Ratings Jul 23, 2020

After William Blair and JMP Securities gave Ovid Therapeutics (NASDAQ: OVID) a Buy rating last month, the company received another Buy, this time from Ladenburg Thalmann & Co. Analyst Michael Higgins maintained a Buy rating on Ovid Therapeutics today and set a price target of $21.00. The company’s shares closed last Wednesday at $7.07. According

William Blair Maintains a Buy Rating on Ovid Therapeutics (OVID)

From Analyst Ratings Jul 17, 2020

In a report issued on July 13, Tim Lugo from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed last Friday at $7.20. According to TipRanks.com, Lugo is a 5-star analyst with an average return of 16.0% and a 50.2% success rate. Lugo covers the Healthcare sector,

Ladenburg Thalmann & Co. Keeps Their Buy Rating on Ovid Therapeutics (OVID)

From Analyst Ratings Jul 13, 2020

Ladenburg Thalmann & Co. analyst Michael Higgins reiterated a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $21.00. The company’s shares closed last Monday at $7.79. According to TipRanks.com, Higgins has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.1%